Alliance Global Partners slashes price target on Verastem Inc. [VSTM] – find out why.

Verastem Inc. [NASDAQ: VSTM] plunged by -$0.3 during the normal trading session on Tuesday and reaching a high of $0.75 during the day while it closed the day at $0.57. The company report on October 4, 2022 that Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


FDA Meeting Planned for Q4 to Discuss Regulatory Path Forward Based on Encouraging Results to Date in Ongoing RAMP 201 Trial in LGSOC.

Results of Part A of RAMP 202 Trial in KRAS G12V-Mutant NSCLC Show VS-6766 ± Defactinib Did Not Meet Criteria to Continue to Expansion Phase.

Verastem Inc. stock has also loss -38.00% of its value over the past 7 days. However, VSTM stock has declined by -51.54% in the 3 months of the year. Over the past six months meanwhile, it has lost -62.63% and lost -72.11% year-on date.

The market cap for VSTM stock reached $109.52 million, with 186.46 million shares outstanding and 186.01 million shares in the current float. Compared to the average trading volume of 1.20M shares, VSTM reached a trading volume of 8108093 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Verastem Inc. [VSTM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VSTM shares is $5.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VSTM stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Alliance Global Partners have made an estimate for Verastem Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 07, 2022. While these analysts kept the previous recommendation, Cantor Fitzgerald dropped their target price from $6 to $5. The new note on the price target was released on April 29, 2022, representing the official price target for Verastem Inc. stock. Previously, the target price had yet another raise to $5, while RBC Capital Mkts analysts kept a Outperform rating on VSTM stock.

The Average True Range (ATR) for Verastem Inc. is set at 0.09, with the Price to Sales ratio for VSTM stock in the period of the last 12 months amounting to 35.33. The Price to Book ratio for the last quarter was 1.97, with the Price to Cash per share for the same quarter was set at 0.49.

VSTM stock trade performance evaluation

Verastem Inc. [VSTM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -38.00. With this latest performance, VSTM shares dropped by -51.54% in over the last four-week period, additionally sinking by -62.63% over the last 6 months – not to mention a drop of -80.28% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VSTM stock in for the last two-week period is set at 19.84, with the RSI for the last a single of trading hit 12.77, and the three-weeks RSI is set at 25.94 for Verastem Inc. [VSTM]. The present Moving Average for the last 50 days of trading for this stock 1.1441, while it was recorded at 0.8191 for the last single week of trading, and 1.3454 for the last 200 days.

Verastem Inc. [VSTM]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Verastem Inc. [VSTM] shares currently have an operating margin of -10372.28 and a Gross Margin at +66.01. Verastem Inc.’s Net Margin is presently recorded at -11749.17.

Return on Equity for this stock declined to -70.21, with Return on Assets sitting at -54.14.

Verastem Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.90 and a Current Ratio set at 4.90.

Earnings per share (EPS) analysis for Verastem Inc. [VSTM] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VSTM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Verastem Inc. go to 1.74%.

Verastem Inc. [VSTM]: Insider Ownership positions

There are presently around $63 million, or 60.20% of VSTM stock, in the hands of institutional investors. The top three institutional holders of VSTM stocks are: BAKER BROS. ADVISORS LP with ownership of 26,988,898, which is approximately 0% of the company’s market cap and around 1.20% of the total institutional ownership; BVF INC/IL, holding 19,974,658 shares of the stock with an approximate value of $11.43 million in VSTM stocks shares; and VIKING GLOBAL INVESTORS LP, currently with $5.28 million in VSTM stock with ownership of nearly New of the company’s market capitalization.

Positions in Verastem Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 46 institutional holders increased their position in Verastem Inc. [NASDAQ:VSTM] by around 18,963,949 shares. Additionally, 76 investors decreased positions by around 25,179,373 shares, while 37 investors held positions by with 65,811,347 shares. The mentioned changes placed institutional holdings at 109,954,669 shares, according to the latest SEC report filing. VSTM stock had 22 new institutional investments in for a total of 11,590,814 shares, while 34 institutional investors sold positions of 3,463,272 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here